ASML vs JNJ
AI-powered side-by-side analysis. Updated every 2 hours.
Divergence: ASML is bearish while JNJ is bullish. Diverging directions between related stocks can signal sector rotation or company-specific catalysts.
ASML raises outlook with record EUV orders
- • Q1 net sales EUR 8.8B, above guidance
- • 2026 revenue guidance raised to EUR 36-40B
- • Plan to ship 60 EUV machines in 2026, 25% increase from 2025
Johnson & Johnson Eyes Double-Digit Revenue Growth
- • JNJ stock up 18.74% in Q1 2026
- • FDA approved ICOTYDE, potentially $5B-$10B sales
- • Insiders sold $127M shares recently
How This Works
The Read analyzes 50+ financial sources every 2 hours and maintains AI-scored positions on 40+ stocks. Each entity is independently evaluated based on insider activity, analyst ratings, earnings data, SEC filings, and news signals. See our track record.
This comparison updates automatically whenever either stock's analysis changes. Every prediction is timestamped and scored against real prices.
More Comparisons
Explore more